Overview
Dr. Weinsaft is a physician-scientist with over a decade-long track record of continuous extramural research support as provided by the National Institutes of Health and other agencies. He has served as principal or co-principal investigator for funded studies investigating new methods to measure blood oxygen saturation in patients with heart failure; diseases of the heart valves and how the valves respond to therapies; and understanding how the major heart artery, the aorta, responds to surgical graft replacement. He is also developing an NIH-funded training program to provide mentorship and training in basic and translational clinical cardiovascular research to trainees at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University.
Highlights
- 1JACC. Cardiovascular imaging · 2020
- 2Journal of the American College of Cardiology · 2020
- 3JACC. Cardiovascular imaging · 2023
Publications
256 publications
Funding
23 grantsView NIH portfolio on RePORTER ↗
Active
7 grants- Co-IR01HL183658-01A1Right Heart Cardiac Magnetic Resonance Tissue Characterization for Clinical and Therapeutic Prognostication in Functional Tricuspid RegurgitationNational Heart, Lung, and Blood Institute · 2026–2031
- MPIR01HL170566-01Cardiac Magnetic Resonance Tissue Characterization of Ischemic and Non-Ischemic Myocardium to Predict Left Ventricular Functional Recovery and Outcomes after Multivessel Coronary RevascularizationNational Heart, Lung, and Blood Institute · 2023–2028
- MPIR01HL170570-04Towards Personalized Prosthetic Graft Replacement for Genetically Triggered Thoracic Aortic AneurysmsNational Heart, Lung, and Blood Institute · 2023–2028
- MPIR61HL151355-01Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's AtaxiaNational Heart, Lung, and Blood Institute · 2020–2027
- Co-IR01HL159055-01Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 SurvivorsNational Heart, Lung, and Blood Institute · 2021–2027
- MPIT32HL160520-01A1Multidisciplinary Research Training in Cardiovascular DiseaseNational Heart, Lung, and Blood Institute · 2022–2027
- MPIR01HL151686-03S1Noninvasive measurement of oxygenation using quantitative susceptibility mapping (supplement)National Heart, Lung, and Blood Institute · 2021–2026· 2 renewals
Completed grants (16)
- Co-IR01HL159433-02Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progressionNational Heart, Lung, and Blood Institute · 2021–2025 · via Icahn School of Medicine at Mount Sinai· 2 renewals
- KPS10OD027039-01A17T Magnetic Resonance Imaging System for Basic, Translational and Clinical ResearchOffice of the Director, NIH · 2021–2025
- Co-IR01HL160392-01Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease RiskNational Heart, Lung, and Blood Institute · 2021–2025
- PICUI 235670-01Towards Personalized Aortic Graft Replacement for Patients with Marfan SyndromeCornell University - Ithaca · 2024–2024
- Sub-PIR01HL154744-04Gadolinium-Free Myocardial Scar and Fibrosis Imaging with Cardiac MRINational Heart, Lung, and Blood Institute · 2020–2024 · via Beth Israel Deaconess Medical Center, Inc.
- Sub-PIMHRI 220797-01HCMR.2 - Hypertrophic Cardiomyopathy RegistryUniversity of Virginia · 2021–2024 · via MedStar Health Research Institute
- Sub-PIU01HL117006-05HCMR.2- Hypertrophic Cardiomyopathy RegistryNational Heart, Lung, and Blood Institute · 2014–2024 · via MedStar Health Research Institute· 2 renewals
- KPK23HL138299-05Impact of Aortic Wall Inflammation and Stiffness on Thoracic Aortic Growth in Marfan SyndromeNational Heart, Lung, and Blood Institute · 2017–2023Career
- PIR01HL128278-05CMR Myocardial Tissue Based Prediction of Ischemic MR Revascularization ResponseNational Heart, Lung, and Blood Institute · 2015–2022
- Co-IFARA 194278-01Gene Therapy for Cardiac Manifestations of Friedreich's AtaxiaFriedreich's Ataxia Research Alliance · 2019–2021
- PINMF 170074-02Cardiovascular Magnetic Resonance Wall Stress Characterization for Prediction of Adverse Aortic Remodeling Following Surgical Aneurysm RepairNational Marfan Foundation · 2018–2020
- PIDUA 201554-01HCMR-Novel Markers of Prognosis in Hypertrophic CardiomyopathyMedStar Health Research Institute · 2019–2020Contract
- KPMF 15091403-02Predictive Value of Inflammation and Arterial Stiffness in Thoracic Aortic AneurysmNational Marfan Foundation · 2015–2018
- KPHHSN268201000084CGenTAC RegistryNational Heart, Lung, and Blood Institute · 2010–2016 · via Research Triangle Institute
- PIK23HL102249-05 EWDelayed Enhancement MRI for Detection of Sub-Clinical Papillary Muscle InfarctionNational Heart, Lung, and Blood Institute · 2010–2016
- KPR01HL064647-08EWOFree Breathing Cardiac MRI SequencesNational Heart, Lung, and Blood Institute · 2008–2012
Clinical research
4 studies
Active
4 studies- PIA Prospective Cohort Study to Investigate Non-Invasive Measurement of Mitral Annulus Calcification Severity Using Cardiac Quantitative Susceptibility MappingWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
- PITowards Personalized Prosthetic Graft Replacement for Thoracic Aortic AneurysmsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
- PINoninvasive Measurement of Oxygenation Using Cardiac Quantitative Susceptibility MappingWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
- PICardiovascular Imaging Manifestations of Coronavirus (COVID-19) InfectionWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
External relationships
Other Interest
Faction Imaging INC
Other
Bitterroot Bio, Inc. · Faction Imaging INC